Mangalam Organics Ltd

  • BSE Code : 514418
  • NSE Symbol : MANORG
  • ISIN : INE370D01013
  • Industry :CHEMICALS

up-arrow 386.40 2.20(0.57%)

Open Price ()

382.30

Prev. Close ()

384.20

Volume (No’s)

5,222

Market Cap ()

330.93

Low Price ()

371.00

High Price ()

410.10

 

Book Closure

From Date To Date Announcement
12-Feb-2026 NA Mangalam Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2026 inter alia to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company along with the Limited Review Report for the third quarter and nine months ended December 31 2025. Pursuant to Regulations 30 and 33 read with Schedule III of the SEBI Listing Regulations, we hereby inform you that the Board of Directors, at its meeting held today, i.e., Thursday, February 12, 2026, inter alia, considered and approved the following: a)Unaudited Standalone and Consolidated Financial Statements of the Company for the Third quarter ended December 31, 2025, which had been duly reviewed and recommended by the Audit Committee. b)The Limited Review Report in respect of the Unaudited Standalone and Consolidated Financial Statements of the Company for Third quarter ended December 31, 2025 (As per BSE Announcement dated on: 12.02.2026)
29-Nov-2025 NA The Board at its meeting held today, i.e., Saturday, November 29, 2025, has approved the working capital loan facility from Axis Bank Limited amounting to Rs. 12 Crore (Rupees Twelve Crore Only) on the terms and conditions as mentioned in the sanction letter. The Company has accordingly entered into a Loan Agreement with Axis Bank Limited for this purpose.
14-Nov-2025 NA Mangalam Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 inter alia to consider and approve 1. To consider and approve the Unaudited Standalone and Consolidated Financial Statements and Limited Review Report of the Company for the Second quarter and Half year ended September 30 2025. 2. Any other business with the permission of the Chair. The Board at its meeting held today, has considered and approved the Standalone and Consolidated Financial Statements for the quarter ended September 30, 2025. (As per BSE Announcement dated on: 14.11.2025)
01-Nov-2025 NA The Board at its meeting held today, has considered and approve the following matters: 1. Unaudited Standalone and Consolidated Financial Statements for the quarter ended June 30, 2025 2. Date of 43rd Annual General Meeting of the Company, draft Board Report along with the cut off date and book closure 3. Updation of Code under Prevention of Insider Trading Regulations 4. Appointment of Auditors and Re-appointment of Directors
29-Sep-2025 NA The Board at its meeting held today, has considered and approve the following matters: 1. Unaudited Standalone and Consolidated Financial Statements for the quarter ended June 30, 2025 2. Date of 43rd Annual General Meeting of the Company, draft Board Report along with the cut off date and book closure 3. Updation of Code under Prevention of Insider Trading Regulations 4. Appointment of Auditors and Re-appointment of Directors

Copyright © 2026 Arihant Capital Markets Ltd. All rights Reserved.

Designed, Developed and Content powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)

x
  • QR-CodeNew